ECYT

Endocyte, Inc. Common Stock
ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

63 hedge funds and large institutions have $11.9M invested in Endocyte, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$108K
Puts
$542K
Net Calls
Net Calls Change

Top Buyers

1 +$274K
2 +$246K
3 +$136K
4
Renaissance Technologies
Renaissance Technologies
New York
+$122K
5
Two Sigma Investments
Two Sigma Investments
New York
+$97K

Top Sellers

1 -$1.55M
2 -$1.05M
3 -$596K
4
Morgan Stanley
Morgan Stanley
New York
-$522K
5
Millennium Management
Millennium Management
New York
-$337K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.45M
2
$2.12M
3
$637K
4
$588K
5
$497K
6
$472K
7
$373K
8
$364K
9
$353K
10
$294K
11
$292K
12
$270K
13
$249K
14
$241K
15
$136K
16
$124K
17
$120K
18
$112K
19
$99K
20
$97K
21
$87K
22
$80K
23
$73K
24
$67K
25
$66K